XENETIC BIOSCIENCES, INC. Amortization of Debt Discount (Premium)
XENETIC BIOSCIENCES, INC. (XBIO) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2018-03-30
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2016 was $544.48K, a 401.70% increase from fiscal 2015.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2015 was $108.53K.
- XENETIC BIOSCIENCES, INC. amortization of debt discount (premium) for fiscal 2014 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $0.00 derived: sum of 2 quarters · filed 2018-03-30 | $0.00 derived: sum of 3 quarters · filed 2018-03-30 | $0.00 10-K · filed 2018-03-30 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $25.38K derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $25.38K derived: sum of 3 quarters · filed 2018-03-30 | $340.48K derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $25.38K derived: sum of 2 quarters · filed 2018-03-30 | $340.48K derived: sum of 3 quarters · filed 2018-03-30 | $404.63K derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-12-31 | $25.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $340.48K derived: sum of 2 quarters · filed 2018-03-30 | $404.63K derived: sum of 3 quarters · filed 2018-03-30 | $544.48K 10-K · filed 2018-03-30 |
| 2016-09-30 | $315.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $379.25K derived: sum of 2 quarters · filed 2017-11-14 | $519.10K 10-Q · filed 2017-11-14 | $576.89K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $64.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $204.00K 10-Q · filed 2017-08-14 | $261.80K derived: sum of 3 quarters · filed 2017-08-14 | $312.53K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $139.85K 10-Q · filed 2017-05-15 | $197.64K derived: sum of 2 quarters · filed 2017-05-15 | $248.37K derived: sum of 3 quarters · filed 2017-05-15 | $248.37K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $57.80K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $108.53K derived: sum of 2 quarters · filed 2017-03-31 | $108.53K derived: sum of 3 quarters · filed 2017-03-31 | $108.53K 10-K · filed 2017-03-31 |
| 2015-09-30 | $50.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $50.73K derived: sum of 2 quarters · filed 2016-11-14 | $50.73K 10-Q · filed 2016-11-14 | $50.73K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $0.00 derived: sum of 3 quarters · filed 2016-08-15 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 | $0.00 derived: sum of 2 quarters · filed 2016-05-16 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |